Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.
about
Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of MyeloperoxidasePharmacology and Clinical Drug Candidates in Redox MedicineA review of the pathophysiology and potential biomarkers for peripheral artery disease.Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.Targeting of Rho kinase ameliorates impairment of diabetic endothelial function in intrarenal artery.Permissive and protective roles for neutrophils in leishmaniasis.Role of neutrophils in atherogenesis: an update.Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems.N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes In Vitro.
P2860
Q26767149-A9581E12-5BF6-44F7-9CC9-2A6289CBE2EBQ26785525-048BB877-FD41-453F-96F2-5A0E72739253Q35723731-9E194691-C4D8-47BB-BEA7-546A6C65B5DBQ36354759-1259BDC6-C097-449B-BB3A-12BEA907FC10Q37139261-E5793900-23F6-4938-9680-04191BDAB83BQ37291276-44978085-4922-43AB-9F5D-44F0F7EF2AC1Q38540870-513D19DD-9E35-487B-BDC0-DEB75F307ED7Q38634721-7DE18490-3A5D-4CB9-935A-5FEE8185EB3DQ38736725-FE722F20-303C-4B6E-9BC8-2414FE58A9A6Q42657336-5917EB6A-35CF-470E-9D80-9A07355F6CFDQ55116295-0AB5188D-5EDF-4D49-BC41-099EBE182CCC
P2860
Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@ast
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@en
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@nl
type
label
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@ast
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@en
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@nl
prefLabel
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@ast
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@en
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@nl
P2093
P2860
P50
P1433
P1476
Effects of a novel pharmacolog ...... a mouse atherosclerosis model.
@en
P2093
Aixia Wang
Cuiqing Liu
Liubov Gushchina
Qinghua Sun
Rajagopal Desikan
Sampath Parthasarathy
Sanjay Rajagopalan
Thomas Kampfrath
Xiaohua Xu
Xiaoquan Rao
P2860
P304
P356
10.1371/JOURNAL.PONE.0050767
P407
P577
2012-12-10T00:00:00Z